Luca De Maso

715 total citations
16 papers, 464 citations indexed

About

Luca De Maso is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Luca De Maso has authored 16 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Hematology. Recurrent topics in Luca De Maso's work include Complement system in diseases (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Blood properties and coagulation (2 papers). Luca De Maso is often cited by papers focused on Complement system in diseases (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Blood properties and coagulation (2 papers). Luca De Maso collaborates with scholars based in Italy, United Kingdom and United States. Luca De Maso's co-authors include Paolo Macor, Paolo Durigutto, Francesco Tedesco, Giannino Del Sal, Raffaella Calligaris, Daniele Sblattero, Marcy E. MacDonald, Roberto Marzari, Francesca Persichetti and Elisa Fossale and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cell Death and Differentiation.

In The Last Decade

Luca De Maso

16 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luca De Maso Italy	10	178	141	81	65	59	16	464
Riccardo Mesturini Italy	15	120 0.7×	184 1.3×	14 0.2×	54 0.8×	18 0.3×	18	481
Annat Raiter Israel	15	238 1.3×	137 1.0×	179 2.2×	12 0.2×	75 1.3×	33	499
Linhua Tian United States	9	224 1.3×	223 1.6×	24 0.3×	55 0.8×	54 0.9×	26	490
Stacey C. Yang United States	9	553 3.1×	102 0.7×	100 1.2×	72 1.1×	63 1.1×	9	757
Alireza Biglari Iran	13	376 2.1×	88 0.6×	68 0.8×	19 0.3×	16 0.3×	50	667
Yuka Hotokezaka Japan	12	342 1.9×	86 0.6×	65 0.8×	17 0.3×	50 0.8×	29	560
Laura Zamurs Australia	7	170 1.0×	107 0.8×	59 0.7×	12 0.2×	14 0.2×	7	393
Yuri Futagami Japan	12	134 0.8×	296 2.1×	38 0.5×	23 0.4×	62 1.1×	14	752
Christine E. Wong Switzerland	11	353 2.0×	42 0.3×	74 0.9×	43 0.7×	14 0.2×	11	625

Countries citing papers authored by Luca De Maso

Since Specialization

Citations

This map shows the geographic impact of Luca De Maso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca De Maso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca De Maso more than expected).

Fields of papers citing papers by Luca De Maso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca De Maso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca De Maso. The network helps show where Luca De Maso may publish in the future.

Co-authorship network of co-authors of Luca De Maso

This figure shows the co-authorship network connecting the top 25 collaborators of Luca De Maso. A scholar is included among the top collaborators of Luca De Maso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca De Maso. Luca De Maso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Maso, Luca De, Marcello Manfredi, Giuseppe Toffoli, et al.. (2024). Stealth-Engineered Albumin-Coated Nanoparticles for Targeted Therapy: Effective Drug Delivery and Tumor Suppression in Xenograft-Zebrafish Model. International Journal of Nanomedicine. Volume 19. 13267–13286. 9 indexed citations

Maso, Luca De, Paolo Bertoncin, Thilo Kähne, et al.. (2023). Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles. Journal of Nanobiotechnology. 21(1). 376–376. 12 indexed citations

Maso, Luca De, et al.. (2022). Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPs. Biomedicines. 10(9). 2252–2252. 6 indexed citations

Cugno, Massimo, Paolo Macor, Mara Giordano, et al.. (2021). Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. Journal of Autoimmunity. 124. 102728–102728. 4 indexed citations

Macor, Paolo, Paolo Durigutto, Alessandro Mangogna, et al.. (2021). Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients. Biomedicines. 9(8). 1003–1003. 50 indexed citations

Bollmann, Miriam, et al.. (2018). Inhibition of the complement system component C5 as possible treatment in OA. Osteoarthritis and Cartilage. 26. S108–S108. 2 indexed citations

Durigutto, Paolo, Daniele Sblattero, Stefania Biffi, et al.. (2017). Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue Damage. Frontiers in Immunology. 8. 1093–1093. 21 indexed citations

Dellepiane, Rosa Maria, Laura Dell’Era, Paolo Macor, et al.. (2016). Invasive meningococcal disease in three siblings with hereditary deficiency of the 8th component of complement: evidence for the importance of an early diagnosis. Orphanet Journal of Rare Diseases. 11(1). 64–64. 8 indexed citations

Macor, Paolo, Sonia Zorzet, Paolo Durigutto, et al.. (2014). Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. Leukemia. 29(2). 406–414. 70 indexed citations

10.

Durigutto, Paolo, Paolo Macor, Luca De Maso, et al.. (2013). Prevention of Arthritis by Locally Synthesized Recombinant Antibody Neutralizing Complement Component C5. PLoS ONE. 8(3). e58696–e58696. 20 indexed citations

11.

Macor, Paolo, Paolo Durigutto, Luca De Maso, et al.. (2012). Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. Arthritis & Rheumatism. 64(8). 2559–2567. 36 indexed citations

12.

Boscolo, Sabrina, Francesca Mion, Paolo Macor, et al.. (2011). Simple scale-up of recombinant antibody production using an UCOE containing vector. New Biotechnology. 29(4). 477–484. 40 indexed citations

13.

Carnemolla, Alisia, Elisa Fossale, Elena Agostoni, et al.. (2009). Rrs1 Is Involved in Endoplasmic Reticulum Stress Response in Huntington Disease. Journal of Biological Chemistry. 284(27). 18167–18173. 133 indexed citations

14.

Macor, Paolo, Paolo Durigutto, Luca De Maso, et al.. (2009). Prevention of antigen-induced arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. Molecular Immunology. 46(14). 2837–2837. 4 indexed citations

15.

Zucchelli, S., Sandra Vilotti, Raffaella Calligaris, et al.. (2008). Aggresome-forming TTRAP mediates pro-apoptotic properties of Parkinson's disease-associated DJ-1 missense mutations. Cell Death and Differentiation. 16(3). 428–438. 47 indexed citations

16.

Macor, Paolo, Paolo Durigutto, Luca De Maso, et al.. (2008). Neutralizing anti-C5 minibody targeted to the endothelium of rat kidney prevents complement-dependent ischaemia/reperfusion injury. Molecular Immunology. 45(16). 4155–4155. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact